« previous next »
Pages: [1]

Author Topic: (Abst.) Advances in oral immunomodulating therapies in relapsing MS  (Read 72 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Advances in oral immunomodulating therapies in relapsing MS
« on: February 17, 2020, 08:41:13 pm »

From PubMed, indexing an article in The Lancet, "Advances in oral immunomodulating therapies in relapsing multiple sclerosis" (February 11, 2020):

https://www.ncbi.nlm.nih.gov/pubmed/32059809/
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
93 Views 		Last post February 14, 2017, 03:05:17 pm
by agate
0 Replies
225 Views 		Last post September 23, 2017, 04:24:24 pm
by agate
0 Replies
90 Views 		Last post August 10, 2018, 09:38:22 am
by agate
0 Replies
43 Views 		Last post January 10, 2021, 04:23:03 pm
by agate
0 Replies
49 Views 		Last post October 07, 2021, 08:52:38 pm
by agate